ORBIMED ADVISORS LLC – Kezar Life Sciences, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$15.25M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+4.11%
quarter
Kezar Life Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +24.78% | 351.8K shares | 3.51M | $8.61 | 1.77M |
| Q2 2022 | share | Increase | 0.00% | 1.41M shares | 11.74M | $8.27 | 1.41M |
| Q4 2021 | call | Decrease | -100.00% | -113.4K shares | -980K | $16.35 | 0 |
| Q4 2021 | share | Decrease | -100.00% | -1.15M shares | -9.93M | $16.35 | 0 |
| Q3 2021 | call | Increase | 0.00% | 113.4K shares | 980K | $8.64 | 113.4K |
| Q3 2021 | share | Increase | +106.39% | 592.80K shares | 6.91M | $8.64 | 1.15M |
| Q2 2021 | share | Increase | 0.00% | 557.19K shares | 3.02M | $5.43 | 557.19K |